Novartis joins urgent relief efforts for victims of earthquake in Haiti
Novartis reached out to the Swiss Red Cross the day after the Haiti earthquake to assist relief efforts drawing on our global healthcare resources. Offers of help from Novartis associates all over the world came into Novartis headquarters in Basel – our people wanting to know how they can best help the victims.
Novartis Pharmaceuticals Canada Inc.: Working to eliminate malaria
A Novartis Pharmaceuticals Canada Inc. employee has returned from a volunteer mission in malaria-stricken Tanzania full of hope that a program he participated in will lead to timely access to life-saving medicines.
Zambezi Expedition puts malaria in the spotlight
Novartis is part of a multi-agency partnership supporting an ambitious journey along the Zambezi River, highlighting the difficulty of delivering mosquito nets and malaria treatment to remote African communities.
NVGH blazes a trail: Effective and affordable vaccines for the developing world
Many eminent scientists are contributing to the Novartis Vaccines Institute for Global Health, the first research center established by a major vaccine manufacturer with a nonprofit mission - to discover and develop vaccines for “neglected” diseases of the developing world.
International Leprosy Congress in Hyderabad
Novartis and the Novartis Foundation for Sustainable Development are working toward the elimination of leprosy. “Toward a world without leprosy” was the motto of the 17th International Leprosy Congress in Hyderabad, India. A world free of leprosy is within reach.
On March 7th, 1996 Sandoz and Ciba-Geigy, the two Swiss-based chemical/life sciences giants, became Novartis
We are a leader in offering medicines to protect health, cure disease and improve well-being.